93
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Hypoxia-inducible factor-1α as prognostic marker

, PharmD, , MSc, , MD PhD & , MD PhD
Pages 53-70 | Published online: 28 Aug 2012

Bibliography

  • Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270(3):1230-7
  • Semenza GL, Wang GL, Kundu R. DNA binding and transcriptional properties of wild-type and mutant forms of the homeodomain protein Msx2. Biochem Biophys Res Commun 1995;209(1):257-62
  • Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001;11(3):293-9
  • Xia X, Lemieux ME, Li W, Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 2009;106(11):4260-5
  • Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92(12):5510-14
  • Gu YZ, Hogenesch JB, Bradfield CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000;40:519-61
  • Hofer T, Wenger H, Gassmann M. Oxygen sensing, HIF-1alpha stabilization and potential therapeutic strategies. Pflugers Arch 2002;443(4):503-7
  • Forsythe JA, Jiang BH, Iyer NV, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16(9):4604-13
  • Kelly BD, Hackett SF, Hirota K, Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93(11):1074-81
  • Ceradini DJ, Kulkarni AR, Callaghan MJ, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-64
  • Tang N, Wang L, Esko J, Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004;6(5):485-95
  • Bosch-Marce M, Okuyama H, Wesley JB, Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007;101(12):1310-18
  • Simon MP, Tournaire R, Pouyssegur J. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 2008;217(3):809-18
  • Jewell UR, Kvietikova I, Scheid A, Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J 2001;15(7):1312-14
  • Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997;272(36):22642-7
  • Jiang BH, Rue E, Wang GL, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996;271(30):17771-8
  • Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95(14):7987-92
  • Jiang BH, Zheng JZ, Leung SW, Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997;272(31):19253-60
  • Semenza GL, Rue EA, Iyer NV, Assignment of the hypoxia-inducible factor 1alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 1996;34(3):437-9
  • Iyer NV, Leung SW, Semenza GL. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 1998;52(2):159-65
  • Gothie E, Richard DE, Berra E, Identification of alternative spliced variants of human hypoxia-inducible factor-1alpha. J Biol Chem 2000;275(10):6922-7
  • Chun YS, Choi E, Yeo EJ, A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses. J Cell Sci 2001;114(Pt 22):4051-61
  • Chun YS, Choi E, Kim TY, A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene. Biochem J 2002;362(Pt 1):71-9
  • Chun YS, Lee KH, Choi E, Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion. Cancer Res 2003;63(24):8700-7
  • Lee KH, Park JW, Chun YS. Non-hypoxic transcriptional activation of the aryl hydrocarbon receptor nuclear translocator in concert with a novel hypoxia-inducible factor-1alpha isoform. Nucleic Acids Res 2004;32(18):5499-511
  • Depping R, Hagele S, Wagner KF, A dominant-negative isoform of hypoxia-inducible factor-1 alpha specifically expressed in human testis. Biol Reprod 2004;71(1):331-9
  • Lukashev D, Sitkovsky M. Preferential expression of the novel alternative isoform I.3 of hypoxia-inducible factor 1alpha in activated human T lymphocytes. Hum Immunol 2008;69(7):421-5
  • Galban S, Gorospe M. Factors interacting with HIF-1alpha mRNA: novel therapeutic targets. Curr Pharm Des 2009;15(33):3853-60
  • Gorlach A. Regulation of HIF-1alpha at the transcriptional level. Curr Pharm Des 2009;15(33):3844-52
  • Srinivas V, Zhang LP, Zhu XH, Caro J. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins. Biochem Biophys Res Commun 1999;260(2):557-61
  • Masson N, Willam C, Maxwell PH, Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 2001;20(18):5197-206
  • Ivan M, Kondo K, Yang H, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (New York, NY) 2001;292(5516):464-8
  • Jaakkola P, Mole DR, Tian YM, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, NY) 2001;292(5516):468-72
  • Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science (New York, NY) 2001;294(5545):1337-40
  • Masson N, Ratcliffe PJ. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci 2003;116(Pt 15):3041-9
  • Brahimi-Horn C, Mazure N, Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 2005;17(1):1-9
  • Jeong JW, Bae MK, Ahn MY, Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002;111(5):709-20
  • Hewitson KS, McNeill LA, Riordan MV, Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 2002;277(29):26351-5
  • Lando D, Peet DJ, Whelan DA, Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science (New York, NY) 2002;295(5556):858-61
  • Sang N, Fang J, Srinivas V, Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol Cell Biol 2002;22(9):2984-92
  • Lando D, Peet DJ, Gorman JJ, FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002;16(12):1466-71
  • Richard DE, Berra E, Gothie E, p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999;274(46):32631-7
  • Lee E, Yim S, Lee SK, Park H. Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol Cells 2002;14(1):9-15
  • Sang N, Stiehl DP, Bohensky J, MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 2003;278(16):14013-19
  • Berta MA, Mazure N, Hattab M, SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity. Biochem Biophys Res Commun 2007;360(3):646-52
  • Bae SH, Jeong JW, Park JA, Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem Biophys Res Commun 2004;324(1):394-400
  • Carbia-Nagashima A, Gerez J, Perez-Castro C, RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 2007;131(2):309-23
  • Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006;70(5):1469-80
  • Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24(2):68-72
  • Seagroves TN, Ryan HE, Lu H, Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol 2001;21(10):3436-44
  • Chen C, Pore N, Behrooz A, Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 2001;276(12):9519-25
  • Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci USA 1994;91(14):6496-500
  • Wheaton WW, Chandel NS. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol 2011;300(3):C385-93
  • Luo W, Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2011;2(7):551-6
  • Luo W, Hu H, Chang R, Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011;145(5):732-44
  • Pescador N, Villar D, Cifuentes D, Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 2010;5(3):e9644
  • Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993;90(9):4304-8
  • Tacchini L, Bianchi L, Bernelli-Zazzera A, Cairo G. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem 1999;274(34):24142-6
  • Lok CN, Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 1999;274(34):24147-52
  • Mukhopadhyay CK, Mazumder B, Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000;275(28):21048-54
  • Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16(10):1151-62
  • Peyssonnaux C, Nizet V, Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle 2008;7(1):28-32
  • Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Ren Physiol 2010;299(1):F1-13
  • Feldser D, Agani F, Iyer NV, Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999;59(16):3915-18
  • Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3(10):721-32
  • Berra E, Milanini J, Richard DE, Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 2000;60(8):1171-8
  • Pelletier J, Bellot G, Gounon P, Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival. Front Oncol 2012;2:18
  • Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004;57(10):1009-14
  • Sowter HM, Ratcliffe PJ, Watson P, HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61(18):6669-73
  • Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97(16):9082-7
  • Vengellur A, LaPres JJ. The role of hypoxia inducible factor 1alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts. Toxicol Sci 2004;82(2):638-46
  • Chen D, Li M, Luo J, Gu W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 2003;278(16):13595-8
  • Hansson LO, Friedler A, Freund S, Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci USA 2002;99(16):10305-9
  • An WG, Kanekal M, Simon MC, Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998;392(6674):405-8
  • Nardinocchi L, Puca R, D'Orazi G. HIF-1alpha antagonizes p53-mediated apoptosis by triggering HIPK2 degradation. Aging 2011;3(1):33-43
  • Sendoel A, Kohler I, Fellmann C, HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 2010;465(7298):577-83
  • Elks PM, van Eeden FJ, Dixon G, Activation of hypoxia-inducible factor-1alpha (Hif-1alpha) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 2011;118(3):712-22
  • Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010;86(2):236-42
  • Manalo DJ, Rowan A, Lavoie T, Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105(2):659-69
  • Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270(22):13333-40
  • Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9(6):669-76
  • Pajusola K, Kunnapuu J, Vuorikoski S, Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 2005;19(10):1365-7
  • Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 2000;6(10):1102-3
  • Huang Y, Shen XJ, Zou Q, Zhao QL. Biological functions of microRNAs. Bioorg Khim 2010;36(6):747-52
  • Loscalzo J. The cellular response to hypoxia: tuning the system with microRNAs. J Clin Invest 2010;120(11):3815-17
  • Shi ZM, Wang J, Yan Z, MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS One 2012;7(3):e32709
  • Liu LZ, Li C, Chen Q, MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One 2011;6(4):e19139
  • Yamakuchi M, Yagi S, Ito T, Lowenstein CJ. MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 2011;6(5):e20291
  • Puissegur MP, Mazure NM, Bertero T, miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 2011;18(3):465-78
  • Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 2011;301(4):H1519-30
  • Mathieu J, Zhang Z, Zhou W, HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 2011;71(13):4640-52
  • Camps C, Buffa FM, Colella S, hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008;14(5):1340-8
  • Dong ZZ, Yao M, Wang L, Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma. Mini Rev Med Chem 2012; Epub ahead of print
  • Soeda A, Park M, Lee D, Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009;28(45):3949-59
  • Covello KL, Kehler J, Yu H, HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006;20(5):557-70
  • Barnhart BC, Simon MC. Metastasis and stem cell pathways. Cancer Metastasis Rev 2007;26(2):261-71
  • McCord AM, Jamal M, Shankavaram UT, Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 2009;7(4):489-97
  • Koh MY, Spivak-Kroizman TR, Powis G. HIF-1alpha and cancer therapy. Recent Results Cancer Res 2010;180:15-34
  • Heddleston JM, Li Z, Lathia JD, Hypoxia inducible factors in cancer stem cells. Br J Cancer 2010;102(5):789-95
  • Qiang L, Wu T, Zhang HW, HIF-1alpha is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 2012;19(2):284-94
  • Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002;2(3):331-41
  • Kojima H, Gu H, Nomura S, Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice. Proc Natl Acad Sci USA 2002;99(4):2170-4
  • Hellwig-Burgel T, Stiehl DP, Wagner AE, Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 2005;25(6):297-310
  • Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9(6):677-84
  • Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 2008;11(2):121-40
  • Zagzag D, Krishnamachary B, Yee H, Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005;65(14):6178-88
  • Kaelin WG Jr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008;8(11):865-73
  • Zundel W, Schindler C, Haas-Kogan D, Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000;14(4):391-6
  • Ravi R, Mookerjee B, Bhujwalla ZM, Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 2000;14(1):34-44
  • Kimbro KS, Simons JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006;13(3):739-49
  • Wilhide ME, Jones WK. Potential therapeutic gene for the treatment of ischemic disease: ad2/hypoxia-inducible factor-1alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element. Mol Pharmacol 2006;69(6):1773-8
  • Rajakumar A, Doty K, Daftary A, Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 2003;24(2-3):199-208
  • Westra J, Brouwer E, van Roosmalen IA, Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor. BMC Musculoskelet Disord 2010;11:61
  • Mowat FM, Luhmann UF, Smith AJ, HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 2010;5(6):e11103
  • Zampell JC, Yan A, Avraham T, HIF-1alpha coordinates lymphangiogenesis during wound healing and in response to inflammation. FASEB J 2012;26(3):1027-39
  • Andrikopoulou E, Zhang X, Sebastian R, Current Insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med 2011;11(3):218-35
  • Jiang C, Lu H, Vincent KA, Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 2002;8(1):23-32
  • Tuder RM, Yun JH, Bhunia A, Fijalkowska I. Hypoxia and chronic lung disease. J Mol Med 2007;85(12):1317-24
  • Semenza GL. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2005;2(1):68-70
  • Rius J, Guma M, Schachtrup C, NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008;453(7196):807-11
  • Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364(7):656-65
  • Cramer T, Yamanishi Y, Clausen BE, HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112(5):645-57
  • Walmsley SR, Cadwallader KA, Chilvers ER. The role of HIF-1alpha in myeloid cell inflammation. Trends Immunol 2005;26(8):434-9
  • Brigati C, Banelli B, di Vinci A, Inflammation, HIF-1, and the epigenetics that follows. Mediators Inflamm 2010;2010:263914
  • Ghosh G, Subramanian IV, Adhikari N, Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 2010;120(11):4141-54
  • Textoris J, Beaufils N, Quintana G, Hypoxia-inducible factor (HIF1alpha) gene expression in human shock states. Crit Care 2012;16(4):R120
  • Zhong H, De Marzo AM, Laughner E, Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999;59(22):5830-5
  • Brahimi-Horn MC, Ben-Hail D, Ilie M, Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. Cancer Res 2012;72(8):2140-50
  • Song X, Liu X, Chi W, Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 2006;58(6):776-84
  • Koukourakis MI, Giatromanolaki A, Sivridis E, Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53(5):1192-202
  • Birner P, Gatterbauer B, Oberhuber G, Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001;92(1):165-71
  • Schindl M, Schoppmann SF, Samonigg H, Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8(6):1831-7
  • Bos R, van der Groep P, Greijer AE, Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003;97(6):1573-81
  • Birner P, Schindl M, Obermair A, Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60(17):4693-6
  • Silva P, Slevin NJ, Sloan P, Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2008;72(5):1551-9
  • Aebersold DM, Burri P, Beer KT, Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001;61(7):2911-16
  • Birner P, Schindl M, Obermair A, Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001;7(6):1661-8
  • Munipalle PC, Viswanath YK, Davis PA, Scoones D. Prognostic value of hypoxia inducible factor 1alpha in esophageal squamous cell carcinoma. Dis Esophagus 2011;24(3):177-81
  • Shintani K, Matsumine A, Kusuzaki K, Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas. Virchows Arch 2006;449(6):673-81
  • Eckert AW, Schutze A, Lautner MH, HIF-1alpha is a prognostic marker in oral squamous cell carcinomas. Int J Biol Markers 2010;25(2):87-92
  • Laughner E, Taghavi P, Chiles K, HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001;21(12):3995-4004
  • Niibe Y, Watanabe J, Tsunoda S, Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501). Eur J Gynaecol Oncol 2010;31(5):491-6
  • Dales JP, Garcia S, Meunier-Carpentier S, Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 2005;116(5):734-9
  • Dales JP, Beaufils N, Silvy M, Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer. BMC Med 2010;8:44
  • Zhong H, Semenza GL, Simons JW, De Marzo AM. Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 2004;28(2):88-93
  • Du Z, Fujiyama C, Chen Y, Masaki Z. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue. Chin Med J (Engl) 2003;116(12):1936-9
  • Daponte A, Ioannou M, Mylonis I, Prognostic significance of hypoxia-inducible factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study. BMC Cancer 2008;8:335
  • Koukourakis MI, Giatromanolaki A, Skarlatos J, Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001;61(5):1830-2
  • Nakanishi K, Hiroi S, Tominaga S, Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Clin Cancer Res 2005;11(7):2583-90
  • Chai CY, Chen WT, Hung WC, Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol 2008;61(5):658-64
  • Ke HL, Wei YC, Yang SF, Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract. Int J Urol 2008;15(3):200-5
  • Beasley NJ, Leek R, Alam M, Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002;62(9):2493-7
  • Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000;20(3A):1527-33
  • Fraga CA, de Oliveira MV, de Oliveira ES, A high HIF-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol 2012;48(2):130-5
  • Kuo WH, Shih CM, Lin CW, Association of hypoxia inducible factor-1alpha polymorphisms with susceptibility to non-small-cell lung cancer. Transl Res 2012;159(1):42-50
  • Pipinikas CP, Carter ND, Corbishley CM, Fenske CD. HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer. Biomarkers 2008;13(7):680-91
  • Li S, Yao D, Wang L, Expression characteristics of hypoxia-inducible factor-1alpha and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Hepat Mon 2011;11(10):821-8
  • Onnis B, Rapisarda A, Melillo G. Development of HIF-1 inhibitors for cancer therapy. J Cell Mol Med 2009;13(9A):2780-6
  • Rapisarda A, Shoemaker RH, Melillo G. Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads. Cell Cycle 2009;8(24):4040-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.